Genetesis has developed CardioFlux, a clinically validated and FDA-cleared biomagnetic imaging device for optimized chest pain triage in the ER
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free